2,535 results on '"Pantel, Klaus"'
Search Results
2. Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma
3. Relationship of Ki-67 index in biopsies of metastatic breast cancer tissue and circulating tumor cells (CTCs) at the time of biopsy collection
4. Functional characterization of PI3K C2 domain mutations detected in breast cancer circulating tumor cells and metastatic cells
5. EpCAM-positive circulating tumor cells and serum AFP levels predict outcome after curative resection of hepatocellular carcinoma
6. Circulating tumour cells for early detection of clinically relevant cancer
7. A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer
8. Circulating tumor cells as liquid biopsy markers in cancer patients
9. Label Efficient Classification in Liquid Biopsy Data by Self-supervision
10. Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value
11. „Liquid biopsy“ – schon reif für Therapieentscheidungen?
12. Experimental in vitro, ex vivo and in vivo models in prostate cancer research
13. Liquid biopsy for monitoring of tumor dormancy and early detection of disease recurrence in solid tumors
14. RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer
15. Association Between Obesity and Circulating Tumor Cells in Early Breast Cancer Patients
16. Efficacy of zoledronic acid for the elimination of disseminated tumor cells in a clinically relevant, spontaneously metastatic prostate cancer xenograft model
17. Preclinical models to study patient-derived circulating tumor cells and metastasis
18. Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions
19. Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade
20. The SURVIVE study: Liquid biopsy guided surveillance after intermediate- to high-risk early breast cancer.
21. Circulating tumor cell-blood cell crosstalk: Biology and clinical relevance
22. Heparan sulfate dependent binding of plasmatic von Willebrand factor to blood circulating melanoma cells attenuates metastasis
23. Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation
24. Tumorigenic circulating tumor cells from xenograft mouse models of non-metastatic NSCLC patients reveal distinct single cell heterogeneity and drug responses
25. Characterization of immunologically detectable T-cell sensitization, Immunohistochemical detection of pro-inflammatory cytokines, and clinical parameters of patients after allogeneic intraoral bone grafting procedures: a prospective randomized controlled clinical trial in humans
26. Regulation of bone homeostasis by MERTK and TYRO3
27. Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma
28. Differential predictive value of tissue‐specific PD‐L1 expression scores in adjuvant immunotherapy of melanoma.
29. Multibiomarker panels in liquid biopsy for early detection of pancreatic cancer – a comprehensive review.
30. Molecular mechanisms of cancer metastasis via the lymphatic versus the blood vessels
31. Elevated levels of Protein S in Multiple Myeloma bone marrow microenvironment regulate tumor progression and bone disease
32. Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cells
33. High Serum Levels of CCL20 Are Associated with Recurrence and Unfavorable Overall Survival in Advanced Melanoma Patients Receiving Immunotherapy
34. TAM receptors control actomyosin dynamics in osteoclasts via RHOA-COFILIN-MYOSIN II signaling
35. NSCLC patients with oligo-metastatic brain disease show an altered CD4 T-cells immune profile
36. HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis
37. Dynamic MicroRNA-Expression In Plasma of Melanoma Patients Correlates With Progression, PD-L1 Status and Overall Survival
38. Pathophysiology of Tumor Cell Release into the Circulation and Characterization of CTC
39. Oncology: Circulating Markers
40. Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis
41. Rationale and Design of the Hamburg City Health Study
42. Two decades of advances in clinical oncology — lessons learned and future directions
43. Novel approaches to target the microenvironment of bone metastasis
44. Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer—Translational Research Results from the Prospective ProMPT trial
45. International liquid biopsy standardization alliance white paper
46. C‐reactive protein flare predicts response to checkpoint inhibitor treatment in melanoma.
47. Master corepressor inactivation through multivalent SLiM-induced polymerization mediated by the oncogene suppressor RAI2.
48. Circulating Giant Tumor-Macrophage Fusion Cells Are Independent Prognosticators in Patients With NSCLC
49. Retinoic Acid-Induced 2 Contributes to Proficient Homologous Recombination and Maintains Genomic Stability in Breast Cancer
50. Circulating Tumor Cells: From Basic to Translational Research
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.